Establishment of Full-Length cDNA Clones and an Efficient Oral Infection Model for Feline Coronavirus in Cats

Tissue- or cell culture-adapted feline infectious peritonitis virus (FIPV) usually loses pathogenicity. To develop a highly virulent FIPV, we constructed a field isolate type I FIPV full-length clone with the spike gene replaced by the 79-1146 spike gene, corresponding to a virus named rQS-79, which induces high mortality in adult cats. rQS-79 represents the first described reverse genetics system for highly pathogenic FCoV. ABSTRACT Feline infectious peritonitis virus (FIPV) is the etiologic agent of feline infectious peritonitis (FIP) and causes fatal disease in cats of almost all ages. Currently, there are no clinically approved drugs or effective vaccines for FIP. Furthermore, the pathogenesis of FIP is still not fully understood. There is an urgent need for an effective infection model of feline infectious peritonitis induced by FIPV. Here, we constructed a field type I FIPV full-length cDNA clone, pBAC-QS, corresponding to the isolated FIPV QS. By replacing the FIPV QS spike gene with the commercially available type II FIPV 79-1146 (79-1146_CA) spike gene, we established and rescued a recombinant virus, designated rQS-79. Moreover, we constructed 79-1146_CA infectious full-length cDNA pBAC-79-1146_CA, corresponding to recombinant feline coronavirus (FCoV) 79-1146_CA (r79-1146_CA). In animal experiments with 1- to 2-year-old adult cats orally infected with the recombinant virus, rQS-79 induced typical FIP signs and 100% mortality. In contrast to cats infected with rQS-79, cats infected with 79-1146_CA did not show obvious signs. Furthermore, by rechallenging rQS-79 in surviving cats previously infected with 79-1146_CA, we found that there was no protection against rQS-79 with different titers of neutralizing antibodies. However, high titers of neutralizing antibodies may help prolong the cat survival time. Overall, we report the first reverse genetics of virulent recombinant FCoV (causing 100% mortality in adult cats) and attenuated FCoV (causing no mortality in adult cats), which will be powerful tools to study pathogenesis, antiviral drugs, and vaccines for FCoV. IMPORTANCE Tissue- or cell culture-adapted feline infectious peritonitis virus (FIPV) usually loses pathogenicity. To develop a highly virulent FIPV, we constructed a field isolate type I FIPV full-length clone with the spike gene replaced by the 79-1146 spike gene, corresponding to a virus named rQS-79, which induces high mortality in adult cats. rQS-79 represents the first described reverse genetics system for highly pathogenic FCoV. By further constructing the cell culture-adapted FCoV 79-1146_CA, we obtained infectious clones of virulent and attenuated FCoV. By in vitro and in vivo experiments, we established a model that can serve to study the pathogenic mechanisms of FIPV. Importantly, the wild-type FIPV replicase skeleton of serotype I will greatly facilitate the screening of antiviral drugs, both in vivo and in vitro.

[1]  K. Hartmann,et al.  Diagnosis of Feline Infectious Peritonitis: A Review of the Current Literature , 2019, Viruses.

[2]  W. Kamitani,et al.  Establishment of a Virulent Full-Length cDNA Clone for Type I Feline Coronavirus Strain C3663 , 2019, Journal of Virology.

[3]  T. Takano,et al.  Pathogenesis of oral type I feline infectious peritonitis virus (FIPV) infection: Antibody-dependent enhancement infection of cats with type I FIPV via the oral route , 2019, The Journal of veterinary medical science.

[4]  S. Xiao,et al.  The N-Terminal Domain of Spike Protein Is Not the Enteric Tropism Determinant for Transmissible Gastroenteritis Virus in Piglets , 2019, Viruses.

[5]  N. Pedersen,et al.  Efficacy and safety of the nucleoside analog GS-441524 for treatment of cats with naturally occurring feline infectious peritonitis , 2019, Journal of feline medicine and surgery.

[6]  Dongbo Sun,et al.  Circulation and genetic diversity of Feline coronavirus type I and II from clinically healthy and FIP‐suspected cats in China , 2018, Transboundary and emerging diseases.

[7]  J. Ziebuhr,et al.  Reverse Genetics for Type I Feline Coronavirus Field Isolate To Study the Molecular Pathogenesis of Feline Infectious Peritonitis , 2018, mBio.

[8]  J. Li,et al.  The S Gene Is Necessary but Not Sufficient for the Virulence of Porcine Epidemic Diarrhea Virus Novel Variant Strain BJ2011C , 2018, Journal of Virology.

[9]  N. Pedersen,et al.  The nucleoside analog GS-441524 strongly inhibits feline infectious peritonitis (FIP) virus in tissue culture and experimental cat infection studies , 2018, Veterinary Microbiology.

[10]  T. Takano,et al.  Antibody-dependent enhancement of serotype II feline enteric coronavirus infection in primary feline monocytes , 2017, Archives of Virology.

[11]  Yingyu Chen,et al.  Establishment of an antibody avidity test to differentiate vaccinated cattle from those naturally infected with Mycoplasma bovis. , 2015, Veterinary journal.

[12]  H. Shimoda,et al.  Emergence of Pathogenic Coronaviruses in Cats by Homologous Recombination between Feline and Canine Coronaviruses , 2014, PloS one.

[13]  I. Sola,et al.  Coronavirus reverse genetic systems: Infectious clones and replicons , 2014, Virus Research.

[14]  Z. Zádori,et al.  Recombinant feline coronaviruses as vaccine candidates confer protection in SPF but not in conventional cats☆ , 2013, Veterinary Microbiology.

[15]  Tengku Ibrahim Tengku Azmi,et al.  Isolation and molecular characterization of type I and type II feline coronavirus in Malaysia , 2012, Virology Journal.

[16]  M. Shimojima,et al.  Feline infectious peritonitis virus with a large deletion in the 5'-terminal region of the spike gene retains its virulence for cats. , 2012, The Journal of general virology.

[17]  D. Spiro,et al.  Spike Protein Fusion Peptide and Feline Coronavirus Virulence , 2012, Emerging infectious diseases.

[18]  L. Enjuanes,et al.  Molecular Characterization of Feline Infectious Peritonitis Virus Strain DF-2 and Studies of the Role of ORF3abc in Viral Cell Tropism , 2012, Journal of Virology.

[19]  N. Pedersen,et al.  Feline infectious peritonitis: Role of the feline coronavirus 3c gene in intestinal tropism and pathogenicity based upon isolates from resident and adopted shelter cats , 2012, Virus Research.

[20]  I. Veiga,et al.  Genetic diversity and phylogenetic analysis of Feline Coronavirus sequences from Portugal , 2009, Veterinary Microbiology.

[21]  N. Pedersen.  A review of feline infectious peritonitis virus infection: 1963–2008 , 2009, Journal of Feline Medicine & Surgery.

[22]  Ching-Ho Wang,et al.  Genetic diversity and correlation with feline infectious peritonitis of feline coronavirus type I and II: A 5-year study in Taiwan , 2008, Veterinary Microbiology.

[23]  T. Takano,et al.  Antibody-dependent enhancement occurs upon re-infection with the identical serotype virus in feline infectious peritonitis virus infection. , 2008, The Journal of veterinary medical science.

[24]  K. Maeda,et al.  Differentiation of feline coronavirus type I and II infections by virus neutralization test , 2007, Veterinary Microbiology.

[25]  N. Pedersen,et al.  Feline Coronavirus Serotypes 1 and 2: Seroprevalence and Association with Disease in Switzerland , 2005, Clinical Diagnostic Laboratory Immunology.

[26]  H. Nauwynck,et al.  Replication of feline coronaviruses in peripheral blood monocytes , 2005, Archives of Virology.

[27]  P. Rottier,et al.  Live, Attenuated Coronavirus Vaccines through the Directed Deletion of Group-Specific Genes Provide Protection against Feline Infectious Peritonitis , 2004, Journal of Virology.

[28]  N. Pedersen,et al.  Disease outcome and cytokine responses in cats immunized with an avirulent feline infectious peritonitis virus (FIPV)-UCD1 and challenge-exposed with virulent FIPV-UCD8 , 2004, Journal of Feline Medicine & Surgery.

[29]  V. Duquesne,et al.  Modified vaccinia virus Ankara as a vaccine against feline coronavirus: immunogenicity and efficacy , 2004, Journal of Feline Medicine & Surgery.

[30]  Viviane Benetka,et al.  Prevalence of feline coronavirus types I and II in cats with histopathologically verified feline infectious peritonitis , 2004, Veterinary Microbiology.

[31]  H. Yamato,et al.  Vaccine efficacy of a cell lysate with recombinant baculovirus-expressed feline infectious peritonitis (FIP) virus nucleocapsid protein against progression of FIP , 2003, Veterinary Microbiology.

[32]  A. Kipar,et al.  Cellular composition, coronavirus antigen expression and production of specific antibodies in lesions in feline infectious peritonitis , 1998, Veterinary Immunology and Immunopathology.

[33]  Marian C. Horzinek,et al.  Feline Coronavirus Type II Strains 79-1683 and 79-1146 Originate from a Double Recombination between Feline Coronavirus Type I and Canine Coronavirus , 1998, Journal of Virology.

[34]  M. Mochizuki,et al.  Antigenic and plaque variations of serotype II feline infectious peritonitis coronaviruses. , 1997, The Journal of veterinary medical science.

[35]  A. Hasegawa,et al.  Characterization of a feline infectious peritonitis virus isolate. , 1991, The Journal of veterinary medical science.

[36]  N. Pedersen,et al.  Pathogenicity studies of feline coronavirus isolates 79-1146 and 79-1683. , 1984, American journal of veterinary research.

[37]  F. Scott,et al.  Antibody-mediated enhancement of disease in feline infectious peritonitis: Comparisons with dengue hemorrhagic fever☆ , 1981, Comparative Immunology, Microbiology and Infectious Diseases.

[38]  K. Fujiwara,et al.  Serodiagnosis for feline infectious peritonitis by immunofluorescence using infected suckling mouse brain sections. , 1981, Nihon juigaku zasshi. The Japanese journal of veterinary science.

[39]  J. Black.  Recovery and in vitro cultivation of a coronavirus from laboratory-induced cases of feline infectious peritonitis (FIP). , 1980, Veterinary medicine, small animal clinician : VM, SAC.